News
Events
Publications
Careers
Volunteer
Blog
Contact
Subscribe via E-mail
Your email:
Follow Me
Industry News
Oldest living kidney donor pleased 'to feel useful'
Imaging HIV in infected cells reveals viral tactics
Arthritis cases will double to reach 17m: charity
Hand hygiene campaign 'cut superbug infections'
Oldest human blood cells are found on iceman's wounds
Most Popular Posts
Quotient Amersham Radiochemicals Update
Drug Transporters Regulatory Guidance Update
Drug-drug Interactions; using In Vitro techniques
Ozenoxacin Activity against Atypical Bacteria
DBS Method Validation
Large Scale Performance Evaluation of MALDI-ToF MS
Plasma Protein Binding Method Comparison Poster at ISSX
Bioanalytical Method Development Strategies
Drug Transporter Interactions; Efflux Testing Strategy
EMA Guidelines on Metabolism Studies Effective Feb 2012
Browse by Tag
14C radiosynthesis (1)
AAPS (3)
Acrolein (1)
ADA (1)
Advantages of labelling with Iodine 125 (1)
agrochemical development (1)
Anomalous Bioanalytical Results (1)
Anti- Drug Antibody (1)
antibiotic resistance surveillance (1)
Antibodies (1)
Anti-Drug Antibody (1)
Antimicrobial Chemotherapy (1)
Antimicrobial Discovery and Development (1)
Applications of PK/PD modelling (1)
ASCPT 2012 (1)
Asthma (1)
Atypical Bacteria (1)
Bacterial identification (1)
BCS class II (4)
bcs II (2)
bioanalytical method development (1)
bioanalytical method development challenges (1)
bioanalytical method development strategies (1)
bioavailability (1)
bioavilability (1)
Biomarkers (2)
Biomarkers Congress 2012 (1)
Biomarkers in Drug Development (1)
Biomarkers of respiratory disease (1)
Biopharmaceuticals (1)
Bruker’s MALDI Biotyper (1)
CAPA system (1)
Carbon-14 radiosynthesis (1)
Cell-Based Assays (1)
Clinical Microbiology (1)
Clinical PD Endpoints (1)
clinical pharmacology (1)
clinical study (1)
clinical testing (1)
clinical trial (2)
COPD (1)
COPD Biomarkers (1)
crop world 2011 (1)
custom peptides service (1)
custom radiolabeling (1)
Custom radiolabelling service (1)
custom radiosynthesis service (1)
CYP450 inhibition (1)
danoprevir (1)
DBS analysis (1)
DDI (1)
Debra Software (1)
Diels Alder Reactions (1)
drug absorption (1)
drug formulations (2)
Drug Transporter Efflux Testing (1)
drug transporter interactions (2)
drug transporter testing (1)
Drug Transporters (1)
Drug transporters regulatory guidance (1)
Drug Transporters Regulatory Landscape (1)
drug-drug interactions (2)
early clinical development (2)
EBF - Open Symposium 2011 (1)
eFate (1)
e-fate (1)
Efflux Transporters testing (1)
EMA Guidelines on Veterinary Medicines (1)
Enterion (1)
environmental fate (1)
Environmental Fate of Veterinary Medicines (1)
formulation technolgy (1)
Formulation_development (2)
Frenolicin B (1)
gastrointestinal transit (1)
GCP Compliance (1)
GI transi (1)
GI transit (1)
Glucagon as a Biomarker (1)
haematocrit assessment (1)
hot and cold peptides (1)
human regional bioavailability (1)
I125 labeling (1)
I125 labelling (1)
ICHM3R2 (1)
IIS Meeting (1)
Immunoassays (1)
Immunogenicity (1)
Immunogenicity Testing (1)
In vitro models for drug transporter assessment (1)
Infectious Diseases (1)
Iodine 125 labeling (1)
Iodine 125 labelling (1)
ISSX posters (1)
ivMicrotracer (1)
labelled peptides (1)
LabLogic (1)
Laura software (1)
Ligand Binding Assays (1)
Ligand-Binding Assays (1)
low level radioactivity counting (1)
MALDI-ToF (1)
Met i.d. (1)
Metabolite i.d. (1)
Metabolite Identification (1)
method validation (1)
microdose (1)
MIQE Guidelines (1)
Molecular Biomarkers (1)
NAbs (1)
Nortilidine (1)
opioids (1)
oral drug delivery (2)
Ozenoxacin (1)
Ozenoxacin activity (1)
PCR (1)
PD (1)
peptide (1)
phase I (1)
phase I clinical trials (1)
PK (1)
PK Modelling and Simulation (1)
PK/PD (1)
Plasma Protein Binding Instrumentation (1)
Plasma Protein Binding Methods (1)
Plasma Protein Binding Techniques (1)
PPB Methods (1)
PPB Techniques (1)
Quotient Amersham Radiochemicals Update (1)
Quotient Bioresearch (1)
Quotient Clinical (3)
radio-iodination (1)
Radiolabelling Service (1)
RapidFACT (2)
Roche (1)
scintigraphy (1)
small molecule LC-MS/MS biomarker methods (1)
Sputum Biomarkers (1)
Synthesis-to-Clinic (1)
Translational Pharmaceutics (1)
Tritium labelled peptides (1)
Tritium Radiolabelling Service (1)
validation of DBS methods (1)
Quotient Bioresearch Blog
Current Articles
|
RSS Feed
Comparison of Assays used for the Detection of Neutralising Antibodies
Iodine 125 Radiolabelling Service
Molecular Biomarkers used to Assess a Novel Treatment of COPD
Drug Transporter Interactions; Efflux Testing Strategy
Making Glucagon work as a Biomarker
Radiolabelled Metabolism Studies Benefit from Software Upgrade
ICHM3R2 Exploratory Clinical Trials; Quotient Clinical posters at ASCPT
EMA Guidelines on Metabolism Studies Effective Feb 2012
Challenges of Validating Small Molecule LC-MS/MS Biomarker Methods
Use of a CAPA System in Handling Anomalous Bioanalytical Results
Drug Transporters - Emerging Technologies
Challenges in Developing Anti-Drug Antibody Ligand Binding Assays
Environmental Fate Presentation at Crop World 2011
14C Radiosynthesis; Diels Alder Solutions to Challenging Syntheses
Plasma Protein Binding Method Comparison Poster at ISSX
Large Scale Performance Evaluation of MALDI-ToF MS
PK Modelling and Simulation to Predict Clinical PD Endpoints
Drug Transporters Regulatory Guidance Update
Why Your Drug Needs Human Regional Bioavailability Data
Bioanalytical Method Development Strategies
Tritium Labelled Peptides Service: Strategic Alliance with CRB
DBS Method Validation
Quantitative Assessment of GI Transit for Opioid Drugs
Quotient Amersham Radiochemicals is now Quotient Custom Radiolabelling
Ozenoxacin Activity against Atypical Bacteria
AAPS Discusses Oral Drug Delivery Strategies - Part 2
AAPS Discusses Oral Drug Delivery Strategies
Quotient Amersham Radiochemicals Update
Sputum Biomarkers of Respiratory Disease
US Clinical Pharmacology Meeting Showcases Breadth of Research
Practical Approaches to Accelerate Early Clinical Development
3 Tips for Overcoming Poor Solubility in Oral Drug Candidates
Drug-drug Interactions; using In Vitro techniques
Quotient Clinical and Bend Research Collaborate
Early Stage Drug Development Platforms
Error sending email
Email sent successfully
Email article
Email To :
Email From :
Message :